Retina in the Setting of Cataract Surgery | ASCRS

Retina in the Setting of Cataract Surgery

Retina in the Setting of Cataract Surgery

Saturday, April 6, 12:00–1:00 p.m.

Learn how retinal diseases and conditions impact the cataract surgeon and comprehensive ophthalmologist’s treatment plans, including what to do with patients presenting with retinal diseases, imaging advances, clinical experiences, and postoperative complications and management. 


Program Co-Chairs

Mike Klufas, MD

Marjan Farid, MD

CME Mission Statement 

ASCRS’ continuing medical education mission is to improve the competence of ophthalmologists/anterior segment surgeons by offering an avenue for the presentation and discussion of innovative techniques and technologies and fostering an open environment where current practices are presented and questions and improvements in patient care are continually sought. 

Accreditation Statement
The American Society of Cataract and Refractive Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality and scientific integrity of the CME activity.

Designation Statement
The American Society of Cataract and Refractive Surgery designates the Retina in the Setting of Cataract Surgery for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Educational Objectives: 

  • Discuss geographic atrophy (GA) and age-related macular degeneration (AMD) and examine how it impacts the cataract surgeon and comprehensive ophthalmologist’s patient treatment plan.
  • Recognize the need for a diagnostic evaluation for patients presenting with retinal diseases.
  • Describe advances in imaging that can improve the diagnosis and treatment of preoperative abnormalities in retinal disorders.
  • Discover and discuss clinical experiences with expert retina specialists to improve clinical and surgical practices and patient care.
  • Discuss post operative complications and develop a comprehensive treatment plan for CME, ERM and floaters.

Disclosure of Financial Interest
All faculty members are required to disclose whether they, or their spouses, have any financial interest (or lack thereof) from the past 24 months with a company that produces, markets, resells or distribute ophthalmic products or services consumed by, or used on, patients. Faculty members are also required to disclose such information verbally and on their first slide.

ASCRS considers presenting authors, no co-authors, to be in control of the educational content. As a professional courtesy, ASCRS acknowledges co-authors and all people contributing to the research, regardless of CME control of the live presentation of that content. Though they are acknowledged, co-authors do not have control of the CME content and their disclosures are not published or resolved. 

Presenter Disclosures
It is an ASCRS requirement that all presenters disclose on the first slide and verbally at the beginning of any presentation whether they have any relevant financial interests from the past 24 months. Presenters are expected to give a fair and balanced presentation.

Notice About Off-Label Use Presentations

The program may include presentations on drugs or devices, or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wished to use in clinical practice. 

ASCRS is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASCRS of the uses, products, or techniques presented.